-
China’s NHSA Releases 2024 Healthcare Security Bulletin Highlighting Insurance Coverage and Reimbursement
•
China’s National Healthcare Security Administration (NHSA) has released its 2024 “Healthcare Security Development Statistical Bulletin.” The report reveals that by the end of 2024, over 1.33 billion people were enrolled in Basic Medical Insurance (BMI) schemes, maintaining a coverage rate of over 95%. Maternity insurance participation reached 252.98 million, an…
-
China Outlines Drug Pricing Reforms, Encourages Insurance Funds for Innovation
•
The Chinese government has released a set of opinions detailing the establishment of a new drug price formation mechanism by 2027, aiming to reduce financing costs for the innovative drug industry and support pharmaceutical innovation. Insurance Fund RoleThe document encourages commercial insurance companies to establish or clarify existing investment funds…
-
In-Depth Analysis of NHSA’s DRG/DIP Payment Reforms: A Path to Streamlined Healthcare Management
•
Comprehensive Overhaul of Payment SystemsThe National Healthcare Security Administration (NHSA) has unveiled a series of measures aimed at enhancing the management of Diagnosis Related Groups (DRG) and Diagnosis-Intervention Packet (DIP) payment methods within China’s multi-tiered healthcare security framework, known as the “1+3+N” system. These reforms emphasize seamless integration with other…
-
NHSA Regulates DRG/DIP Payment Methods Under ‘1+3+N’ System
•
The National Healthcare Security Administration (NHSA) has released a set of regulations aimed at improving the management of Diagnosis Related Groups (DRG) and Diagnosis-Intervention Packet (DIP) payment methods under the multi-level medical security system of “1+3+N”. The document emphasizes the need for better coordination between payment methods and reforms in…
-
China’s NHSA and MoF Push for DRG/DIP Payment Reforms by 2025
•
The National Healthcare Security Administration (NHSA) and the Ministry of Finance (MoF) have jointly released a notification requiring all provinces to include the direct settlement of hospitalization expenses in other places within the province in the Diagnosis Related Groups (DRG) and Diagnosis-Intervention Packet (DIP) payment systems by the end of…
-
NHSA Targets Low-Volume Drugs in National Reimbursement List
•
The National Healthcare Security Administration (NHSA) in China has released a list of 131 drugs that are included in the National Reimbursement Drug List (NRDL) but have seen little trade volume. The move aims to ensure the basic medication needs of insured patients by monitoring the production and supply of…
-
NHSA Pushes for Real-Time Settlement Reform in Basic Medical Insurance
•
The National Healthcare Security Administration (NHSA) has released a notification to promote the real-time settlement reform of the basic medical insurance (BMI) fund. The goal is to achieve real-time settlement in about 80% of the overall planning areas in China by 2025, with all areas expected to implement the reform…
-
NHSA Launches Nationwide Self-Inspection Campaign on Medical Insurance Fund Usage
•
China’s National Healthcare Security Administration (NHSA) released a notification last weekend, mandating designated medical institutions to conduct self-inspections and self-corrections regarding the illegal and irregular use of medical insurance funds. This initiative aims to enhance the integrity and efficiency of fund utilization within the healthcare sector. Expansion of Campaign ScopeThis…
-
China’s NHSA Implements New Regulations for Medical Insurance Payment Qualifications
•
China’s National Healthcare Security Administration (NHSA) has released the “Regulations on the Management of Medical Insurance Payment Qualifications for Personnel in Medical Security Designated Medical Institutions.” These regulations aim to enhance the rational use of medical insurance funds and maintain fund security through improved management efforts. The document came into…
-
Beijing Conference Outlines 2025 Healthcare Security Goals and 2024 Progress
•
A national conference on healthcare security was recently held in Beijing, reviewing the achievements of 2024 and setting the agenda for 2025. The conference highlighted new developments in medical reform across various fronts. Advancements in Medical Reform in 2024 Universal Insurance CoverageThe conference reported that universal insurance coverage has entered…
-
Beijing Expands Medical Insurance Sharing to Near Relatives with New Policy
•
The Beijing Municipal Medical Insurance Bureau has released a notification that significantly expands the scope of employee medical insurance individual accounts to be shared among family members. This policy now includes not only immediate relatives—spouse, parents, and children—but also near relatives, which encompasses siblings, grandparents, maternal grandparents, and grandchildren. To…
-
National Reimbursement Drug List (NRDL) Negotiations Conclude with Lower Generic Drug Approval Rate
•
The National Reimbursement Drug List (NRDL) negotiations for the year have concluded, with less than 50% of the total 162 participating generic name drugs passing the expert review. This approval rate is a decrease compared to 74.2% in 2022 and 63.8% in 2023. The successful drugs included 117 varieties from…
-
Hunan Province Includes Fertility Treatments in Medical Insurance Coverage from October 2024
•
The Hunan Healthcare Security Administration has issued a notification to include specific assisted reproductive medical services within the payment scope of Basic Medical Insurance (BMI) and Work Injury Insurance Funds, effective from October 1, 2024, for a period of five years. Under this policy, a total of eight items, including…
-
AstraZeneca Faces Investigation in China Over Data Privacy and Unapproved Drugs
•
AstraZeneca (NASDAQ: AZN), a leading UK pharmaceutical company, is reportedly under the spotlight in Shenzhen, China, with an investigation involving five current and former employees, as per a report by Bloomberg. The probe is said to center on potential breaches of data privacy regulations and the unauthorized importation of drugs…
-
China Unveils 2024 Plan to Combat Fraud in Medical Insurance Funds
•
The National Healthcare Security Administration (NHSA) of China, in conjunction with the Supreme People’s Court, the Supreme People’s Procuratorate, the Ministry of Public Security, the Ministry of Finance, and the National Health Commission, has unveiled the “2024 Special Work Plan for the Rectification of Illegal and Non-compliant Issues Related to…
-
Chinese Authorities Launch Special Plan to Rectify Medical Insurance Fraud and Non-Compliance
•
The National Healthcare Security Administration (NHSA) of China, in collaboration with the Supreme People’s Court, Supreme People’s Procuratorate, Ministry of Public Security, Ministry of Finance, and National Health Commission, has jointly issued the “2024 Special Work Plan for the Rectification of Illegal and Non-compliant Issues Related to Medical Insurance Funds.”…
-
Hebei Province Proposes Measures for ‘Internet+’ Medical Services and Insurance Management
•
The Hebei provincial Healthcare Security Administration (HSA) bureau has released a draft set of Measures titled “Hebei ‘Internet+’ Medical Service, Medical Insurance Management Measures,” which are now in effect and open for public comment until March 31, 2024. The document outlines the process for Internet medical institutions conducting “Internet +”…
-
Hunan Province Hospitals Commit to Implementing Nationally Negotiated Drugs in Policy Seminar
•
A policy seminar under the auspices of the Hunan Healthcare Security Administration bureau convened in Changsha, the capital of Hunan province, with the objective of ensuring the implementation of newly nationally negotiated drugs included in the National Reimbursement Drug List (NRDL). The event resulted in a consensus among hospital leaders…
-
China Regulators Chart Steady Path for ‘Huiminbao’ Medical Insurance Schemes
•
The China Banking and Insurance Regulatory Commission (CBIRC) and National Healthcare Security Administration (NHSA) have issued a notification outlining measures to ensure a stable and orderly implementation of urban ‘Huiminbao’ commercial top-up medical insurance schemes. The notice is open for feedback from insurance companies and industry associations nationwide. The document…
-
China’s NHSA Aims to Balance Drug Prices with New Monitoring System by March 2024
•
The National Healthcare Security Administration (NHSA) has issued a notification aimed at fostering inter-provincial price fairness, integrity, transparency, and balance for drugs sharing the same generic names and manufacturers. The initiative involves a comprehensive review and inspection of drugs based on four criteria: generic name, manufacturer, dosage form, and specification.…
